Jacob A. Orville, General Manager, Screening at EXACT SCIENCES CORP (EXAS), sold 3,758 shares at $56.89 ($214K) on 2024-02-27, disclosed to the SEC on 2024-02-28.
Scheduled sale ($214k) by General Manager, Screening under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.89 | 1,879 | $107K | 50.0% |
| 2 | $56.89 | 1,879 | $107K | 50.0% |
| Total | $56.89 avg | 3,758 | $214K | 100% |
| Filing → |
| EXAS | SELL | 2024-03-04 | $256K | — | Filing → |
| EXAS | SELL | 2024-02-23 | $121K | — | Filing → |
| EXAS | SELL | 2024-02-22 | $66K | — | Filing → |